nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—Leukotriene Receptor Antagonists—Montelukast—chronic obstructive pulmonary disease	0.436	1	CiPCiCtD
Zafirlukast—asthma—chronic obstructive pulmonary disease	0.268	1	CtDrD
Zafirlukast—CYP1A2—chronic obstructive pulmonary disease	0.0852	1	CbGaD
Zafirlukast—CYSLTR1—Montelukast—chronic obstructive pulmonary disease	0.0834	0.52	CbGbCtD
Zafirlukast—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.00873	0.0545	CbGbCtD
Zafirlukast—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.00756	0.0472	CbGbCtD
Zafirlukast—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.00558	0.0348	CbGbCtD
Zafirlukast—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.00558	0.0348	CbGbCtD
Zafirlukast—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.00504	0.0314	CbGbCtD
Zafirlukast—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.00464	0.0289	CbGbCtD
Zafirlukast—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.00464	0.0289	CbGbCtD
Zafirlukast—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00438	0.0273	CbGbCtD
Zafirlukast—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00424	0.0264	CbGbCtD
Zafirlukast—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00424	0.0264	CbGbCtD
Zafirlukast—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00378	0.0236	CbGbCtD
Zafirlukast—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.0222	CbGbCtD
Zafirlukast—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00351	0.0219	CbGbCtD
Zafirlukast—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0024	0.015	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00234	0.0146	CbGbCtD
Zafirlukast—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00229	0.0143	CbGbCtD
Zafirlukast—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00204	0.0127	CbGbCtD
Zafirlukast—CYSLTR2—respiratory system—chronic obstructive pulmonary disease	0.00134	0.29	CbGeAlD
Zafirlukast—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00748	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00706	CbGbCtD
Zafirlukast—CYSLTR2—lung—chronic obstructive pulmonary disease	0.000709	0.154	CbGeAlD
Zafirlukast—CYSLTR1—respiratory system—chronic obstructive pulmonary disease	0.000503	0.109	CbGeAlD
Zafirlukast—CYSLTR1—bronchus—chronic obstructive pulmonary disease	0.000414	0.0899	CbGeAlD
Zafirlukast—CYSLTR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000405	0.0879	CbGeAlD
Zafirlukast—CYSLTR1—lung—chronic obstructive pulmonary disease	0.000267	0.058	CbGeAlD
Zafirlukast—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.000171	0.00546	CcSEcCtD
Zafirlukast—Injury—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00544	CcSEcCtD
Zafirlukast—Blister—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00529	CcSEcCtD
Zafirlukast—Injury—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00525	CcSEcCtD
Zafirlukast—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000162	0.00516	CcSEcCtD
Zafirlukast—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00016	0.0051	CcSEcCtD
Zafirlukast—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000154	0.00491	CcSEcCtD
Zafirlukast—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.00458	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000141	0.00451	CcSEcCtD
Zafirlukast—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000141	0.0306	CbGeAlD
Zafirlukast—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00014	0.00447	CcSEcCtD
Zafirlukast—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000136	0.00435	CcSEcCtD
Zafirlukast—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00428	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000134	0.00427	CcSEcCtD
Zafirlukast—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000134	0.00426	CcSEcCtD
Zafirlukast—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000128	0.00408	CcSEcCtD
Zafirlukast—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000127	0.0276	CbGeAlD
Zafirlukast—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000127	0.00404	CcSEcCtD
Zafirlukast—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000123	0.00393	CcSEcCtD
Zafirlukast—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000123	0.00391	CcSEcCtD
Zafirlukast—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.0039	CcSEcCtD
Zafirlukast—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000122	0.0265	CbGeAlD
Zafirlukast—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00378	CcSEcCtD
Zafirlukast—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00376	CcSEcCtD
Zafirlukast—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00369	CcSEcCtD
Zafirlukast—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00369	CcSEcCtD
Zafirlukast—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.00369	CcSEcCtD
Zafirlukast—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000114	0.00364	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00364	CcSEcCtD
Zafirlukast—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00362	CcSEcCtD
Zafirlukast—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00362	CcSEcCtD
Zafirlukast—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00358	CcSEcCtD
Zafirlukast—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000111	0.00355	CcSEcCtD
Zafirlukast—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00349	CcSEcCtD
Zafirlukast—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.00348	CcSEcCtD
Zafirlukast—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00346	CcSEcCtD
Zafirlukast—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00344	CcSEcCtD
Zafirlukast—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000108	0.0234	CbGeAlD
Zafirlukast—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000106	0.00338	CcSEcCtD
Zafirlukast—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00335	CcSEcCtD
Zafirlukast—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00334	CcSEcCtD
Zafirlukast—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00332	CcSEcCtD
Zafirlukast—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.00328	CcSEcCtD
Zafirlukast—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000103	0.00327	CcSEcCtD
Zafirlukast—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000102	0.00324	CcSEcCtD
Zafirlukast—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000102	0.00324	CcSEcCtD
Zafirlukast—Contusion—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.00317	CcSEcCtD
Zafirlukast—Vomiting—Roflumilast—chronic obstructive pulmonary disease	9.86e-05	0.00314	CcSEcCtD
Zafirlukast—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	9.84e-05	0.0214	CbGeAlD
Zafirlukast—Rash—Roflumilast—chronic obstructive pulmonary disease	9.78e-05	0.00312	CcSEcCtD
Zafirlukast—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	9.77e-05	0.00312	CcSEcCtD
Zafirlukast—Oedema—Tiotropium—chronic obstructive pulmonary disease	9.75e-05	0.00311	CcSEcCtD
Zafirlukast—Headache—Roflumilast—chronic obstructive pulmonary disease	9.71e-05	0.0031	CcSEcCtD
Zafirlukast—Infection—Tiotropium—chronic obstructive pulmonary disease	9.69e-05	0.00309	CcSEcCtD
Zafirlukast—Injury—Prednisolone—chronic obstructive pulmonary disease	9.43e-05	0.00301	CcSEcCtD
Zafirlukast—Insomnia—Aminophylline—chronic obstructive pulmonary disease	9.35e-05	0.00298	CcSEcCtD
Zafirlukast—Back pain—Formoterol—chronic obstructive pulmonary disease	9.33e-05	0.00297	CcSEcCtD
Zafirlukast—Back pain—Arformoterol—chronic obstructive pulmonary disease	9.33e-05	0.00297	CcSEcCtD
Zafirlukast—Nausea—Roflumilast—chronic obstructive pulmonary disease	9.21e-05	0.00294	CcSEcCtD
Zafirlukast—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	9.1e-05	0.0029	CcSEcCtD
Zafirlukast—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	9.07e-05	0.00289	CcSEcCtD
Zafirlukast—PTGS1—trachea—chronic obstructive pulmonary disease	9.03e-05	0.0196	CbGeAlD
Zafirlukast—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	8.95e-05	0.00285	CcSEcCtD
Zafirlukast—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	8.95e-05	0.00285	CcSEcCtD
Zafirlukast—Vasculitis—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.00284	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8.88e-05	0.00283	CcSEcCtD
Zafirlukast—Insomnia—Tiotropium—chronic obstructive pulmonary disease	8.82e-05	0.00281	CcSEcCtD
Zafirlukast—Angioedema—Formoterol—chronic obstructive pulmonary disease	8.81e-05	0.00281	CcSEcCtD
Zafirlukast—Angioedema—Arformoterol—chronic obstructive pulmonary disease	8.81e-05	0.00281	CcSEcCtD
Zafirlukast—Back pain—Salbutamol—chronic obstructive pulmonary disease	8.81e-05	0.00281	CcSEcCtD
Zafirlukast—Malaise—Formoterol—chronic obstructive pulmonary disease	8.7e-05	0.00277	CcSEcCtD
Zafirlukast—Malaise—Arformoterol—chronic obstructive pulmonary disease	8.7e-05	0.00277	CcSEcCtD
Zafirlukast—Angioedema—Montelukast—chronic obstructive pulmonary disease	8.63e-05	0.00275	CcSEcCtD
Zafirlukast—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	8.58e-05	0.00274	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	8.46e-05	0.0027	CcSEcCtD
Zafirlukast—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	8.45e-05	0.00269	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	8.42e-05	0.00269	CcSEcCtD
Zafirlukast—Angioedema—Salbutamol—chronic obstructive pulmonary disease	8.32e-05	0.00265	CcSEcCtD
Zafirlukast—Urticaria—Aminophylline—chronic obstructive pulmonary disease	8.21e-05	0.00262	CcSEcCtD
Zafirlukast—Malaise—Salbutamol—chronic obstructive pulmonary disease	8.21e-05	0.00262	CcSEcCtD
Zafirlukast—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	8.21e-05	0.00262	CcSEcCtD
Zafirlukast—Arthralgia—Formoterol—chronic obstructive pulmonary disease	8.21e-05	0.00262	CcSEcCtD
Zafirlukast—Myalgia—Arformoterol—chronic obstructive pulmonary disease	8.21e-05	0.00262	CcSEcCtD
Zafirlukast—Myalgia—Formoterol—chronic obstructive pulmonary disease	8.21e-05	0.00262	CcSEcCtD
Zafirlukast—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	8.17e-05	0.00261	CcSEcCtD
Zafirlukast—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	8.17e-05	0.00261	CcSEcCtD
Zafirlukast—Neuropathy—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.0026	CcSEcCtD
Zafirlukast—Discomfort—Arformoterol—chronic obstructive pulmonary disease	8.11e-05	0.00259	CcSEcCtD
Zafirlukast—Discomfort—Formoterol—chronic obstructive pulmonary disease	8.11e-05	0.00259	CcSEcCtD
Zafirlukast—Myalgia—Montelukast—chronic obstructive pulmonary disease	8.04e-05	0.00256	CcSEcCtD
Zafirlukast—Arthralgia—Montelukast—chronic obstructive pulmonary disease	8.04e-05	0.00256	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	7.97e-05	0.00254	CcSEcCtD
Zafirlukast—Oedema—Arformoterol—chronic obstructive pulmonary disease	7.87e-05	0.00251	CcSEcCtD
Zafirlukast—Oedema—Formoterol—chronic obstructive pulmonary disease	7.87e-05	0.00251	CcSEcCtD
Zafirlukast—Infection—Arformoterol—chronic obstructive pulmonary disease	7.82e-05	0.00249	CcSEcCtD
Zafirlukast—Infection—Formoterol—chronic obstructive pulmonary disease	7.82e-05	0.00249	CcSEcCtD
Zafirlukast—ABCG2—lung—chronic obstructive pulmonary disease	7.78e-05	0.0169	CbGeAlD
Zafirlukast—Myalgia—Salbutamol—chronic obstructive pulmonary disease	7.75e-05	0.00247	CcSEcCtD
Zafirlukast—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	7.75e-05	0.00247	CcSEcCtD
Zafirlukast—Urticaria—Tiotropium—chronic obstructive pulmonary disease	7.75e-05	0.00247	CcSEcCtD
Zafirlukast—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	7.71e-05	0.00246	CcSEcCtD
Zafirlukast—Oedema—Montelukast—chronic obstructive pulmonary disease	7.71e-05	0.00246	CcSEcCtD
Zafirlukast—Discomfort—Salbutamol—chronic obstructive pulmonary disease	7.66e-05	0.00244	CcSEcCtD
Zafirlukast—Infection—Montelukast—chronic obstructive pulmonary disease	7.66e-05	0.00244	CcSEcCtD
Zafirlukast—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	7.62e-05	0.00243	CcSEcCtD
Zafirlukast—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	7.55e-05	0.00241	CcSEcCtD
Zafirlukast—CYP1A2—lung—chronic obstructive pulmonary disease	7.49e-05	0.0163	CbGeAlD
Zafirlukast—Oedema—Salbutamol—chronic obstructive pulmonary disease	7.43e-05	0.00237	CcSEcCtD
Zafirlukast—Infection—Salbutamol—chronic obstructive pulmonary disease	7.38e-05	0.00235	CcSEcCtD
Zafirlukast—Pruritus—Aminophylline—chronic obstructive pulmonary disease	7.32e-05	0.00233	CcSEcCtD
Zafirlukast—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	7.18e-05	0.00229	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	7.17e-05	0.00229	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	7.17e-05	0.00229	CcSEcCtD
Zafirlukast—Insomnia—Formoterol—chronic obstructive pulmonary disease	7.12e-05	0.00227	CcSEcCtD
Zafirlukast—Insomnia—Arformoterol—chronic obstructive pulmonary disease	7.12e-05	0.00227	CcSEcCtD
Zafirlukast—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	7.07e-05	0.00226	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	7.02e-05	0.00224	CcSEcCtD
Zafirlukast—Insomnia—Montelukast—chronic obstructive pulmonary disease	6.97e-05	0.00222	CcSEcCtD
Zafirlukast—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	6.93e-05	0.00221	CcSEcCtD
Zafirlukast—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	6.93e-05	0.00221	CcSEcCtD
Zafirlukast—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.9e-05	0.0022	CcSEcCtD
Zafirlukast—Injury—Prednisone—chronic obstructive pulmonary disease	6.86e-05	0.00219	CcSEcCtD
Zafirlukast—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.84e-05	0.00218	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.79e-05	0.00217	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.79e-05	0.00217	CcSEcCtD
Zafirlukast—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.78e-05	0.00216	CcSEcCtD
Zafirlukast—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.78e-05	0.00216	CcSEcCtD
Zafirlukast—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.78e-05	0.00216	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.77e-05	0.00216	CcSEcCtD
Zafirlukast—CYP2E1—lung—chronic obstructive pulmonary disease	6.74e-05	0.0146	CbGeAlD
Zafirlukast—Pain—Arformoterol—chronic obstructive pulmonary disease	6.73e-05	0.00215	CcSEcCtD
Zafirlukast—Pain—Formoterol—chronic obstructive pulmonary disease	6.73e-05	0.00215	CcSEcCtD
Zafirlukast—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.72e-05	0.00214	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.65e-05	0.00212	CcSEcCtD
Zafirlukast—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.65e-05	0.00212	CcSEcCtD
Zafirlukast—Pain—Montelukast—chronic obstructive pulmonary disease	6.59e-05	0.0021	CcSEcCtD
Zafirlukast—Vomiting—Aminophylline—chronic obstructive pulmonary disease	6.57e-05	0.0021	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	6.55e-05	0.00209	CcSEcCtD
Zafirlukast—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	6.54e-05	0.00209	CcSEcCtD
Zafirlukast—Rash—Aminophylline—chronic obstructive pulmonary disease	6.52e-05	0.00208	CcSEcCtD
Zafirlukast—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	6.51e-05	0.00208	CcSEcCtD
Zafirlukast—PTGS1—lung—chronic obstructive pulmonary disease	6.49e-05	0.0141	CbGeAlD
Zafirlukast—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	6.48e-05	0.00207	CcSEcCtD
Zafirlukast—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	6.48e-05	0.00207	CcSEcCtD
Zafirlukast—Headache—Aminophylline—chronic obstructive pulmonary disease	6.48e-05	0.00207	CcSEcCtD
Zafirlukast—Dizziness—Tiotropium—chronic obstructive pulmonary disease	6.45e-05	0.00206	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	6.43e-05	0.00205	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	6.43e-05	0.00205	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	6.42e-05	0.00205	CcSEcCtD
Zafirlukast—Fatigue—Salbutamol—chronic obstructive pulmonary disease	6.41e-05	0.00204	CcSEcCtD
Zafirlukast—Pain—Salbutamol—chronic obstructive pulmonary disease	6.35e-05	0.00203	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	6.3e-05	0.00201	CcSEcCtD
Zafirlukast—Urticaria—Formoterol—chronic obstructive pulmonary disease	6.25e-05	0.00199	CcSEcCtD
Zafirlukast—Urticaria—Arformoterol—chronic obstructive pulmonary disease	6.25e-05	0.00199	CcSEcCtD
Zafirlukast—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	6.22e-05	0.00198	CcSEcCtD
Zafirlukast—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	6.22e-05	0.00198	CcSEcCtD
Zafirlukast—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	6.22e-05	0.00198	CcSEcCtD
Zafirlukast—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	6.22e-05	0.00198	CcSEcCtD
Zafirlukast—Vomiting—Tiotropium—chronic obstructive pulmonary disease	6.2e-05	0.00198	CcSEcCtD
Zafirlukast—Rash—Tiotropium—chronic obstructive pulmonary disease	6.15e-05	0.00196	CcSEcCtD
Zafirlukast—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	6.14e-05	0.00196	CcSEcCtD
Zafirlukast—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.14e-05	0.00196	CcSEcCtD
Zafirlukast—Urticaria—Montelukast—chronic obstructive pulmonary disease	6.12e-05	0.00195	CcSEcCtD
Zafirlukast—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	6.12e-05	0.00195	CcSEcCtD
Zafirlukast—Headache—Tiotropium—chronic obstructive pulmonary disease	6.11e-05	0.00195	CcSEcCtD
Zafirlukast—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	6.09e-05	0.00194	CcSEcCtD
Zafirlukast—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	6.09e-05	0.00194	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	6.08e-05	0.00194	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	6.03e-05	0.00192	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	6e-05	0.00191	CcSEcCtD
Zafirlukast—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.9e-05	0.00188	CcSEcCtD
Zafirlukast—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	5.87e-05	0.00187	CcSEcCtD
Zafirlukast—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.87e-05	0.00187	CcSEcCtD
Zafirlukast—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.8e-05	0.00185	CcSEcCtD
Zafirlukast—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.8e-05	0.00185	CcSEcCtD
Zafirlukast—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.79e-05	0.00185	CcSEcCtD
Zafirlukast—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.68e-05	0.00181	CcSEcCtD
Zafirlukast—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.65e-05	0.0018	CcSEcCtD
Zafirlukast—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.65e-05	0.0018	CcSEcCtD
Zafirlukast—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.57e-05	0.00178	CcSEcCtD
Zafirlukast—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.57e-05	0.00178	CcSEcCtD
Zafirlukast—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.53e-05	0.00176	CcSEcCtD
Zafirlukast—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	5.47e-05	0.00175	CcSEcCtD
Zafirlukast—Pruritus—Montelukast—chronic obstructive pulmonary disease	5.45e-05	0.00174	CcSEcCtD
Zafirlukast—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	5.38e-05	0.00172	CcSEcCtD
Zafirlukast—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	5.38e-05	0.00172	CcSEcCtD
Zafirlukast—Asthenia—Salbutamol—chronic obstructive pulmonary disease	5.33e-05	0.0017	CcSEcCtD
Zafirlukast—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5.27e-05	0.00168	CcSEcCtD
Zafirlukast—Pruritus—Salbutamol—chronic obstructive pulmonary disease	5.26e-05	0.00168	CcSEcCtD
Zafirlukast—Dizziness—Formoterol—chronic obstructive pulmonary disease	5.2e-05	0.00166	CcSEcCtD
Zafirlukast—Dizziness—Arformoterol—chronic obstructive pulmonary disease	5.2e-05	0.00166	CcSEcCtD
Zafirlukast—Dizziness—Montelukast—chronic obstructive pulmonary disease	5.1e-05	0.00163	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.00162	CcSEcCtD
Zafirlukast—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	5.08e-05	0.00162	CcSEcCtD
Zafirlukast—Vomiting—Formoterol—chronic obstructive pulmonary disease	5e-05	0.0016	CcSEcCtD
Zafirlukast—Vomiting—Arformoterol—chronic obstructive pulmonary disease	5e-05	0.0016	CcSEcCtD
Zafirlukast—Rash—Arformoterol—chronic obstructive pulmonary disease	4.96e-05	0.00158	CcSEcCtD
Zafirlukast—Rash—Formoterol—chronic obstructive pulmonary disease	4.96e-05	0.00158	CcSEcCtD
Zafirlukast—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.96e-05	0.00158	CcSEcCtD
Zafirlukast—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.96e-05	0.00158	CcSEcCtD
Zafirlukast—Headache—Formoterol—chronic obstructive pulmonary disease	4.93e-05	0.00157	CcSEcCtD
Zafirlukast—Headache—Arformoterol—chronic obstructive pulmonary disease	4.93e-05	0.00157	CcSEcCtD
Zafirlukast—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.91e-05	0.00157	CcSEcCtD
Zafirlukast—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.9e-05	0.00156	CcSEcCtD
Zafirlukast—Rash—Montelukast—chronic obstructive pulmonary disease	4.86e-05	0.00155	CcSEcCtD
Zafirlukast—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.86e-05	0.00155	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	4.85e-05	0.00155	CcSEcCtD
Zafirlukast—Headache—Montelukast—chronic obstructive pulmonary disease	4.83e-05	0.00154	CcSEcCtD
Zafirlukast—Angioedema—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.00152	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.00152	CcSEcCtD
Zafirlukast—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.72e-05	0.00151	CcSEcCtD
Zafirlukast—Malaise—Prednisolone—chronic obstructive pulmonary disease	4.71e-05	0.0015	CcSEcCtD
Zafirlukast—Rash—Salbutamol—chronic obstructive pulmonary disease	4.69e-05	0.00149	CcSEcCtD
Zafirlukast—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.68e-05	0.00149	CcSEcCtD
Zafirlukast—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.67e-05	0.00149	CcSEcCtD
Zafirlukast—Nausea—Formoterol—chronic obstructive pulmonary disease	4.67e-05	0.00149	CcSEcCtD
Zafirlukast—Headache—Salbutamol—chronic obstructive pulmonary disease	4.65e-05	0.00148	CcSEcCtD
Zafirlukast—Nausea—Montelukast—chronic obstructive pulmonary disease	4.58e-05	0.00146	CcSEcCtD
Zafirlukast—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.41e-05	0.00141	CcSEcCtD
Zafirlukast—Discomfort—Prednisolone—chronic obstructive pulmonary disease	4.39e-05	0.0014	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.0014	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.00139	CcSEcCtD
Zafirlukast—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.26e-05	0.00136	CcSEcCtD
Zafirlukast—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.85e-05	0.00123	CcSEcCtD
Zafirlukast—Pain—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.00116	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	3.52e-05	0.00112	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	3.51e-05	0.00112	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.00111	CcSEcCtD
Zafirlukast—Malaise—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.00109	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.39e-05	0.00108	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.00103	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.00103	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—chronic obstructive pulmonary disease	3.19e-05	0.00102	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	3.14e-05	0.001	CcSEcCtD
Zafirlukast—Oedema—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000988	CcSEcCtD
Zafirlukast—Infection—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000981	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.0009	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.82e-05	0.000899	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000893	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.73e-05	0.00087	CcSEcCtD
Zafirlukast—Rash—Prednisolone—chronic obstructive pulmonary disease	2.69e-05	0.000857	CcSEcCtD
Zafirlukast—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.68e-05	0.000856	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000852	CcSEcCtD
Zafirlukast—Headache—Prednisolone—chronic obstructive pulmonary disease	2.67e-05	0.000852	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.000814	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.53e-05	0.000808	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.53e-05	0.000807	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.46e-05	0.000785	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000781	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000781	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.28e-05	0.000728	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000709	CcSEcCtD
Zafirlukast—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.19e-05	0.000699	CcSEcCtD
Zafirlukast—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.12e-05	0.000676	CcSEcCtD
Zafirlukast—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.05e-05	0.000653	CcSEcCtD
Zafirlukast—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.97e-05	0.000628	CcSEcCtD
Zafirlukast—Rash—Prednisone—chronic obstructive pulmonary disease	1.95e-05	0.000623	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.95e-05	0.000622	CcSEcCtD
Zafirlukast—Headache—Prednisone—chronic obstructive pulmonary disease	1.94e-05	0.000619	CcSEcCtD
Zafirlukast—Nausea—Prednisone—chronic obstructive pulmonary disease	1.84e-05	0.000587	CcSEcCtD
Zafirlukast—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000932	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000926	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.39e-05	0.00092	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.37e-05	0.000909	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.34e-05	0.000889	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000884	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.33e-05	0.00088	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000877	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.32e-05	0.000876	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	0.000872	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.32e-05	0.00087	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.31e-05	0.000867	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000865	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.000863	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000856	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000851	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	1.28e-05	0.000844	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.28e-05	0.000844	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	1.23e-05	0.000812	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000806	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000795	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000795	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.2e-05	0.000794	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.18e-05	0.000783	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.000781	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.17e-05	0.000775	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000772	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000772	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000764	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000754	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.09e-05	0.000724	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.00072	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.09e-05	0.000719	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	1.08e-05	0.000715	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000714	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	1.08e-05	0.000711	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.07e-05	0.00071	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000709	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000709	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.06e-05	0.000704	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.06e-05	0.000704	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.06e-05	0.000701	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000682	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000679	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000678	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.02e-05	0.000678	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000673	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.000671	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1e-05	0.000662	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	9.92e-06	0.000656	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.92e-06	0.000656	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.92e-06	0.000656	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	9.9e-06	0.000655	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.87e-06	0.000653	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.85e-06	0.000651	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.78e-06	0.000647	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	9.73e-06	0.000643	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	9.73e-06	0.000643	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	9.65e-06	0.000638	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.53e-06	0.00063	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.53e-06	0.00063	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.48e-06	0.000627	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.45e-06	0.000625	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.4e-06	0.000622	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.35e-06	0.000619	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.35e-06	0.000619	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	9.29e-06	0.000615	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.27e-06	0.000613	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	9.27e-06	0.000613	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	9.26e-06	0.000613	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	9.26e-06	0.000613	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.22e-06	0.00061	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.1e-06	0.000602	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.09e-06	0.000601	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.97e-06	0.000593	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.62e-06	0.00057	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.53e-06	0.000564	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.47e-06	0.000561	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.42e-06	0.000557	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.36e-06	0.000553	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	8.29e-06	0.000549	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.18e-06	0.000541	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.12e-06	0.000537	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.03e-06	0.000531	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.92e-06	0.000524	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.83e-06	0.000518	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.69e-06	0.000509	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	7.63e-06	0.000505	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	7.56e-06	0.0005	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.48e-06	0.000494	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.43e-06	0.000491	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.38e-06	0.000488	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.14e-06	0.000472	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.12e-06	0.000471	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.12e-06	0.000471	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.1e-06	0.00047	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.02e-06	0.000464	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	6.93e-06	0.000458	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.87e-06	0.000454	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.63e-06	0.000438	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.6e-06	0.000437	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.54e-06	0.000433	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	6.46e-06	0.000427	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.45e-06	0.000427	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.44e-06	0.000426	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.33e-06	0.000419	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.2e-06	0.00041	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.16e-06	0.000407	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.11e-06	0.000404	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.1e-06	0.000404	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.02e-06	0.000398	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.99e-06	0.000396	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.91e-06	0.000391	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.73e-06	0.000379	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.57e-06	0.000368	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.49e-06	0.000363	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.45e-06	0.00036	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.43e-06	0.000359	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.39e-06	0.000357	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	5.35e-06	0.000354	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.27e-06	0.000349	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.21e-06	0.000345	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.18e-06	0.000343	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.14e-06	0.00034	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.06e-06	0.000335	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.05e-06	0.000334	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.01e-06	0.000331	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.01e-06	0.000331	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.99e-06	0.00033	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.97e-06	0.000329	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.97e-06	0.000329	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.95e-06	0.000327	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	4.92e-06	0.000325	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.87e-06	0.000322	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.76e-06	0.000315	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.72e-06	0.000312	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.67e-06	0.000309	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.63e-06	0.000306	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.62e-06	0.000306	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.61e-06	0.000305	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.57e-06	0.000302	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.57e-06	0.000302	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.53e-06	0.0003	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.44e-06	0.000293	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.39e-06	0.00029	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.38e-06	0.00029	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.28e-06	0.000283	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.21e-06	0.000278	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.17e-06	0.000276	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	4.16e-06	0.000275	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.97e-06	0.000263	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.96e-06	0.000262	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.89e-06	0.000257	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.87e-06	0.000256	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.78e-06	0.00025	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.74e-06	0.000247	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.65e-06	0.000242	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.61e-06	0.000239	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.6e-06	0.000238	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.56e-06	0.000236	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.56e-06	0.000235	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.51e-06	0.000232	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.46e-06	0.000229	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.41e-06	0.000226	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.36e-06	0.000222	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.3e-06	0.000219	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.27e-06	0.000216	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.27e-06	0.000216	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-06	0.000214	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.23e-06	0.000213	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.21e-06	0.000213	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.21e-06	0.000212	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.18e-06	0.000211	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.15e-06	0.000208	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.08e-06	0.000204	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.06e-06	0.000202	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.02e-06	0.000199	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.99e-06	0.000198	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.95e-06	0.000195	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.92e-06	0.000193	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.89e-06	0.000191	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.72e-06	0.00018	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.69e-06	0.000178	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.69e-06	0.000178	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.69e-06	0.000178	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.66e-06	0.000176	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.65e-06	0.000176	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.63e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.63e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.62e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.59e-06	0.000171	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.47e-06	0.000163	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.45e-06	0.000162	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.43e-06	0.000161	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.42e-06	0.00016	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.41e-06	0.000159	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.4e-06	0.000159	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.29e-06	0.000151	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.28e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.27e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.25e-06	0.000149	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.24e-06	0.000148	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.23e-06	0.000148	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.21e-06	0.000146	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	2.16e-06	0.000143	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.1e-06	0.000139	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-06	0.000138	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.08e-06	0.000137	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-06	0.000137	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-06	0.000136	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.02e-06	0.000134	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2e-06	0.000132	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.99e-06	0.000132	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.98e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.86e-06	0.000123	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.86e-06	0.000123	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.85e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.84e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.82e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.76e-06	0.000117	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.76e-06	0.000116	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.74e-06	0.000115	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.71e-06	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.7e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.62e-06	0.000107	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.61e-06	0.000106	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-06	0.000105	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-06	0.000103	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.55e-06	0.000103	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.49e-06	9.83e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-06	9.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-06	9.59e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-06	9.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-06	8.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-06	8.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-06	8.05e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-06	7.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.2e-06	7.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.15e-06	7.58e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-06	7.4e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.1e-06	7.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-06	7.23e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-06	7.01e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.05e-06	6.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.05e-06	6.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	9.34e-07	6.18e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.93e-07	5.91e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.21e-07	4.77e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.89e-07	4.56e-05	CbGpPWpGaD
